| Osprey Medical, Inc. engages in the development, and commercialization of its proprietary products for the prevention of harmful effect of X-ray dye used during commonly performed angiographic imaging procedures. Its product includes Dyevert system, which is designed to reduce the amount of dye contrast injected into the patients during standard cardiovascular procedures. The company was founded by Frank Solomon, David Kaye, and James Edward Shapland on August 31, 2005 and is headquartered in Minnetonka, MN. |
